Skip to main content

Table 2 Distribution of ESBL-GNB colonization sites in a subgroup of patients with at least one rectal swab available

From: Colonization sites in carriers of ESBL-producing Gram-negative bacteria

Sample site/type

Colonization rectum only (N = 326)

%

Colonization rectum + other site

(N = 180)

%

No colonization rectum (N = 82)

%

Total

(N = 588)

%

Rectum

326

100,0

180

100,0

–

–

506

86,1

Respiratory tract & Pleural aspirate

–

–

93

51,7

25

30,5

118

20,1

Urogenital tract

–

–

72

40,0

33

40,2

105

17,9

Pus

–

–

47

26,1

21

25,6

68

11,6

Blood & Intravenous or arterial catheter tip

–

–

29

16,1

9

11,0

38

6,5

Other

–

–

29

16,1

3

3,7

32

5,4

Ascites/Bile/Drain/Feces

–

–

13

7,2

6

7,3

19

3,2

Biopsy & Aspirate

–

–

11

6,1

2

2,4

13

2,2

Ear & Nose

–

–

2

1,1

1

1,2

3

0,5

Central Nervous System

–

–

1

0,6

–

–

1

0,2

Joint prosthesis

–

–

1

0,6

–

–

1

0,2

  1. Data for all patients included in the subgroup-analysis (n = 588) and data stratified per patient group: rectal colonization only (55,4%), rectum plus another site colonized (30,6%), and no rectal colonization (13,9%)